BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34463970)

  • 21. Genomic testing in myeloid malignancy.
    Docking TR; Karsan A
    Int J Lab Hematol; 2019 May; 41 Suppl 1():117-125. PubMed ID: 31069982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-throughput sequencing of B- and T-lymphocyte antigen receptors in hematology.
    Warren EH; Matsen FA; Chou J
    Blood; 2013 Jul; 122(1):19-22. PubMed ID: 23656731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An overview of genetic predisposition to familial hematological malignancies.
    Hamadou WS; Bouali N; Besbes S; Mani R; Bardakci F; Siddiqui AJ; Badraoui R; Adnan M; Sobol H; Soua Z
    Bull Cancer; 2021; 108(7-8):718-724. PubMed ID: 34052033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bracha Ramot (1927-2006).
    Ben-Bassat I; Raanani P
    Blood Cells Mol Dis; 2007; 39(2):135-9. PubMed ID: 17957832
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of new technologies in the detection of balanced translocations in hematologic disorders.
    Shaffer LG; Schultz RA; Ballif BC
    Curr Opin Genet Dev; 2012 Jun; 22(3):264-71. PubMed ID: 22336526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evolving clinical testing landscape of genomic aberrations in solid tumors and hematological malignancies - Insights from evidence-based reviews for B-ALL and breast, brain, and renal cell neoplasia.
    Miron PM; Fang M
    Cancer Genet; 2020 Jun; 244():60-61. PubMed ID: 32473557
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experimental hematology bridging the gap between laboratory and clinic: hope of hematology].
    Chen Z; Chen SJ; Zhou GB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):1-21. PubMed ID: 18315892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetics in hematology: introduction.
    Beris P
    Semin Hematol; 2013 Jan; 50(1):15. PubMed ID: 23507480
    [No Abstract]   [Full Text] [Related]  

  • 29. Metaphase FISH, microdissection, and multicolour FISH. Applications in haematology.
    Mecucci C; Falzetti D; La Starza R
    Haematologica; 1999 Jun; 84 Suppl EHA-4():98-101. PubMed ID: 10907483
    [No Abstract]   [Full Text] [Related]  

  • 30. Next-generation sequencing-based panel testing for myeloid neoplasms.
    Kuo FC; Dong F
    Curr Hematol Malig Rep; 2015 Jun; 10(2):104-11. PubMed ID: 25933675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Introduction to Genomics in Hematologic Malignancy.
    Ebert BL; Friedberg JW
    J Clin Oncol; 2017 Mar; 35(9):927-928. PubMed ID: 28297621
    [No Abstract]   [Full Text] [Related]  

  • 32. [Genetic translocations in oncohematology].
    Novik AA; Kamilova TA; Tsygan VN
    Vopr Onkol; 2002; 48(6):629-38. PubMed ID: 12530255
    [No Abstract]   [Full Text] [Related]  

  • 33. [Histone deacetylase inhibitors in the treatment of hematological malignancies].
    Lemal R; Ravinet A; Moluçon-Chabrot C; Bay JO; Guièze R
    Bull Cancer; 2011 Aug; 98(8):867-78. PubMed ID: 21827981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Implementing next-generation sequencing for precision hematology/oncology].
    Maeda T
    Rinsho Ketsueki; 2018; 59(10):1924-1934. PubMed ID: 30305493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomics in hematologic malignancies.
    Foà R; Hoffbrand VA
    Rev Clin Exp Hematol; 2005 Jun; 9(1):1 p preceding E1. PubMed ID: 16874950
    [No Abstract]   [Full Text] [Related]  

  • 36. [Recommendations for laboratory standardization of next generation sequencing in hematological malignancies].
    Xu CS; Li XQ; Liu HX; Li CB; Chen Z; Cai JP; Peng MT
    Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(41):3204-3208. PubMed ID: 31694113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic evaluation and considerations in hypocellular bone marrow failure-A focus on genomics.
    Fox LC; Wood EM; Ritchie DS; Blombery P
    Int J Lab Hematol; 2020 Jun; 42 Suppl 1():82-89. PubMed ID: 32134198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies.
    Coccaro N; Tota G; Anelli L; Zagaria A; Specchia G; Albano F
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discussing and managing hematologic germ line variants.
    Kohlmann W; Schiffman JD
    Blood; 2016 Nov; 128(21):2497-2503. PubMed ID: 27881370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WGS and WTS in leukaemia: A tool for diagnostics?
    Meggendorfer M; Walter W; Haferlach T
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101190. PubMed ID: 33038979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.